Buerglen, 11.25.2005
From Fritz Frei
Prof. Kevin Ault, Gynaecologist, from the Emory University
School of Medicine, University of Iowa, USA has present
the results of the last Study's conclusions are
Incredible and it's true; he told about a vaccine, that
is 100 % effective in preventing the most common types
of Cervical cancer linked to HPV (D3-to see).
The HPV infections are sexually transmitted diseases
which prepare the way for cervical cancer. We can protect
the women against the most Carcinogenic subtypes (6, 11,
16 and 18 of HPV) which are the cause of More than 70 %
of cervical cancers.
With optimistic results of the Future II study, 20541
Women from Europe, America and Asia, between the ages of
16 and 26 years old, was involved in this extensive
project. Of course, the methodological rules, as a blind
Study compared the quadrivalent vaccine do a placebo. The
Vaccine protected the young women completely against
precancerous Lesions (medium - or high-grad) of the
Cervix related to HPV 16 and 18. The protection result br> was
100 % of cases! The sid-effects comes with an
extremely low number. If we see the large number of cases
in this study, the results should be the same if
vaccination is made Available to the public.
We should not forget - the Cervical Cancer is the second
leading cancer in Young women and accounts for 11 % of
Cancers in all women! When the Women has a common genital
Infection with the human papillomavirus (HPV) and its can
result in the appearance of precancerous lesions of the
Cervix Mucous membrane. For instance, we know that the
connection between HPV infection and cervical cancer is
much stronger than that between smoking and lung cancer.
How the researcher has got these results? With this new
quadrivalent vaccine for cervical cancer, the most
oncogenic subtypes of HPV can now be whipped out. One of
the first steps is vaccinating adolescents
(D3-"Chronical") Before they come into contact with the
virus; - Results - No virus, no Lesions - no cancer!
Prevention - the essential part of the combating Cervical
Cancer.
The most oncogenic subtypes of HPV can now be wiped out
thanks to this new quadrivalent vaccine. The first step
is vaccinating adolescents (D3 - "Chronical") before they
come into contact with the virus; this is a turning point
in the fight against cancer. It is a major tool in the
prevention of precancerous lesions in the cervix. No
virus, no lesions -- and if there are no lesions, that
means no cancer. Prevention is an essential part of the
equation when it comes to combating cervical cancer --
that's why oncologists are so excited about the new
Vaccine.
A study conducted with more than 20,000 women has shown
the absolute effectiveness of a vaccine in the prevention
of cervical cancer due to the most common types of human
papillomavirus (HPV). Oncologists are enthusiastic. It is
a rare thing to hear physicians -- and even more so,
oncologists --get excited to the point of speaking of a
"historical breakthrough" after hearing a presentation
from a colleague.
Prof. Thomas Turz, Director of the Institute Gustave
Roussy at the ECCO conference has say - It is a rare
thing to hear physicians -- and even more so, oncologists
--get excited to the point of speaking of a "historical
breakthrough" after hearing a presentation from a
colleague. The Oncologists are enthusiastic.
Health-Service-Online
Admin Fritz Frei
|
